Legal Opinion
State v. Par Pharmaceutical, Inc.
Supreme Court of Alabama
Decided September 30, 2010No. 1090992 and 1090994PublishedCited by 6 opinions
1Opinion of the Court
SMITH, Justice.
In two separate petitions, Par Pharmaceutical, Inc., and Mylan Inc. (formerly known as Mylan Laboratories, Inc.), Mylan *769Pharmaceuticals Inc., and UDL Laboratories, Inc., petition this Court for a writ of mandamus, asking us to vacate an order of the Montgomery Circuit Court that consolidates for a single trial under Rule 42, Ala. R. Civ. P., the cases filed against the petitioners by the State of Alabama as a part of cases the State has filed against multiple pharmaceutical companies. See generally AstraZeneca LP v. State, 41 So.3d 15 (Ala.2009). We deny the petitions.
Facts and…
2Cases cited22 opinions
- Ex Parte Integon Corp.Supreme Court of Alabama · 1995
- Aubrey Hendrix v. Raybestos-Manhattan, Inc.Court of Appeals for the Eleventh Circuit · 1985
- Ex Parte EdgarSupreme Court of Alabama · 1989
- Sanders v. Empire Fire and Marine Ins. Co.Supreme Court of Alabama · 1998
- State Farm Fire & Cas. Co. v. OwenSupreme Court of Alabama · 1999
17 more not listed; retrieve them via the Exa API.
3Cited by6 opinions
- State v. Abbott LaboratoriesWisconsin Supreme Court · 2012
- Wilson v. ThomasSupreme Court of Alabama · 2012
- Whatley v. HigginbothamSupreme Court of Alabama · 2013
- Sims v. Sims (Ex parte Sims)Court of Civil Appeals of Alabama · 2017
- Howell v. Alfa Ins. Corp. (In re Alfa Ins. Corp.)Supreme Court of Alabama · 2018
1 more not listed; retrieve them via the Exa API.